ReviewFrontiers in oncology2022

Engaging innate immunity for targeting the epidermal growth factor receptor: Therapeutic options leveraging innate immunity versus adaptive immunity versus inhibition of signaling.

Gabriele Hintzen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.